NIH Common Fund Data Ecosystem (CFDE) FAIR Rubric

A rubric for evaluating the FAIRness of NIH-CFDE Resources

Tags: nihcommonfund

URL(s):

View Associations

Rubric Assessments (626384)


Assessment Metrics Date
Target Project   Contact information is provided for the creator(s) of the dataset. Globally unique identifier Machine-readable metadata Standardized metadata Resource identifier in metadata Open, Free, Standardized Access protocol Digital resource license Metadata license NIH program name is available for querying NIH project name is available for querying The institution that created this dataset is available A biological assay is present and resolvable in CFDE-specified ontology (OBI) A relevant anatomical part is present and resolvable in the UBERON Ontology A relevant disease is present and resolvable in the MONDO Ontology A relevant file type is present and resolvable in the EDAM Ontology A relevant taxonomy is present and resolvable in the NCBITaxon Ontology A relevant cell line is present and resolvable in the Cellosaurus Ontology A landing page exists and is accessible
Abemaciclib KINOMEscan LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yes (0.80)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
CP-690550 KINOMEscan LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yes (0.80)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
5z-7-oxozeaenol KINOMEscan LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yes (0.80)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
CI-1040 KINOMEscan LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yes (0.80)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
CG-930 KINOMEscan LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yes (0.80)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
AZD-1152HQPA KINOMEscan-2 LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yes (0.80)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
AG1478 KINOMEscan LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yes (0.80)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
CGP74514A KINOMEscan LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yes (0.80)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
BEZ235 KINOMEscan LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yes (0.80)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Breast Cancer Profiling Project - Proteomics 2: 1 phosphoproteome dataset (including phosphotyrosine enrichment) for a 35-cell line breast cancer panel under basal conditions LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yes (0.84)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Dinaciclib KINOMEscan LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yes (0.80)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Aggregated ChEMBL bioactivity data (v20) LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yesbut (0.76)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Aggregated Tox21 bioactivity data LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yes (0.84)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
CI-1033 KINOMEscan LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yes (0.80)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
BMS-540215 KINOMEscan LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yes (0.80)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
AZ-628 KiNativ -- dose response experiment LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yesbut (0.76)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
BIBW-2992 KINOMEscan LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yes (0.80)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
ALW-II-38-3 KINOMEscan LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yes (0.80)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
BYL719 KINOMEscan LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yes (0.80)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Cell signaling response to cytokines measured by high throughput microscopy LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yesbut (0.76)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
AC220 KINOMEscan LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yes (0.80)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
BMS-536924 KINOMEscan LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yes (0.80)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Average variable importance in the projection (VIP) scores from the PLSR models analyzing the covariation of molecular signals with cell viability and apoptosis fraction in BRAF(V600E/D) melanoma cell lines LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yes (0.84)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
BMS-387032 KINOMEscan LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yes (0.80)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. LINCS: Assessment of NIH Common Fund Resources with C2M2
yes (1.00) no (0.00) yes (0.80)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yes (1.00) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019